Millennium Management’s Cogent Biosciences COGT Stock Holding History

Millennium Management’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$45.9M	Sell	1,192,406 -15,822	-1%	-$584K	0.02%	883
2025 Q4	$42.9M	Buy	1,208,228 +793,262	+191%	+$22.3M	0.02%	907
2025 Q3	$5.96M	Sell	414,966 -555,007	-57%	-$6.58M	﹤0.01%	2958
2025 Q2	$6.96M	Buy	969,973 +455,475	+89%	+$2.53M	﹤0.01%	2632
2025 Q1	$3.08M	Buy	514,498 +457,986	+810%	+$3.59M	﹤0.01%	3361
2024 Q4	$441K	Sell	56,512 -1,557,104	-96%	-$15.5M	﹤0.01%	4840
2024 Q3	$17.4M	Buy	1,613,616 +381,759	+31%	+$3.72M	0.01%	1669
2024 Q2	$10.4M	Sell	1,231,857 -1,124,069	-48%	-$8.53M	﹤0.01%	2045
2024 Q1	$15.8M	Sell	2,355,926 -441,318	-16%	-$2.73M	0.01%	1746
2023 Q4	$16.4M	Buy	2,797,244 +2,673,555	+2,162%	+$20.5M	0.01%	1703
2023 Q3	$1.21M	Sell	123,689 -496,327	-80%	-$5.89M	﹤0.01%	4034
2023 Q2	$7.34M	Buy	620,016 +600,774	+3,122%	+$6.89M	﹤0.01%	2317
2023 Q1	$208K	Sell	19,242 -180,940	-90%	-$2.31M	﹤0.01%	5148
2022 Q4	$2.31M	Buy	+200,182	New	+$2.48M	﹤0.01%	3457
2022 Q3	–	Sell	-447,634	Closed	-$4.04M	–	7113
2022 Q2	$4.04M	Buy	447,634 +411,773	+1,148%	+$2.81M	﹤0.01%	3017
2022 Q1	$269K	Sell	35,861 -14,314	-29%	-$99.7K	﹤0.01%	5639
2021 Q4	$431K	Buy	+50,175	New	+$436K	﹤0.01%	5191
2021 Q2	–	Sell	-766,326	Closed	-$6.73M	–	6586
2021 Q1	$6.73M	Buy	766,326 +720,323	+1,566%	+$6.93M	﹤0.01%	2250
2020 Q4	$517K	Sell	46,003 -256,370	-85%	-$2.82M	﹤0.01%	4167
2020 Q3	$2.83K	Buy	+302,373	New	+$3.15M	﹤0.01%	2318
2020 Q2	–	Sell	-33,460	Closed	-$55K	–	4214
2020 Q1	$55K	Sell	33,460 -12,362	-27%	-$34.4K	﹤0.01%	3649
2019 Q4	$132K	Sell	45,822 -21,931	-32%	-$89.5K	﹤0.01%	3969
2019 Q3	$390K	Sell	67,753 -30,515	-31%	-$248K	﹤0.01%	3416
2019 Q2	$1.03M	Buy	98,268 +80,227	+445%	+$1.07M	﹤0.01%	2796
2019 Q1	$317K	Buy	+18,041	New	+$308K	﹤0.01%	3520
2018 Q4	–	Sell	-5,587	Closed	-$230K	–	3798
2018 Q3	$230K	Buy	+5,587	New	+$315K	﹤0.01%	3585
2018 Q2	–	Sell	-22,101	Closed	-$982K	–	3825
2018 Q1	$982K	Buy	+22,101	New	+$982K	﹤0.01%	2696

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Millennium Management's COGT Position: Q1 2026 in Review

Millennium Management reduced its Cogent Biosciences (COGT) stake by 1.3% in Q1 2026, selling an estimated $584K and leaving 1,192,406 shares worth $45.9M. The position accounts for 0.02% of the portfolio, ranked #883.

Millennium Management first reported a position in COGT in Q1 2018 and has held it in 27 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

Millennium Management held 1,192,406 shares of Cogent Biosciences worth $45.9M as of Q1 2026.
Millennium Management sold 15,822 Cogent Biosciences shares in Q1 2026, an estimated $584K.
Cogent Biosciences made up 0.02% of Millennium Management's portfolio in Q1 2026, its #883 holding.
Millennium Management first reported a position in Cogent Biosciences in Q1 2018 and has held it in 27 quarters since.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.